Clinical Trials in New York State

Showing 7441-7460 of 13,041 trials

A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies

NCT03205046

This study evaluates the safety of acalabrutinib and vistusertib when taken in combination.

Acerta Pharma BV25 participantsStarted Jun 2017

Fairway, Kansas, United States • Bethesda, Maryland, United States • Rochester, Minnesota, United States +8 more locations

COMPLETEDPhase 3100 miles

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

NCT01578499

The purpose of this study is to determine objective response rate (ORR), lasting at least 4 months (ORR4), with brentuximab vedotin in participants with cluster of differentiation antigen 30 positive (CD30+) cutaneous T-cell lymphoma \[mycosis fungoides (MF) and primary cutaneous anaplastic large cell lymphoma (pcALCL) \]compared to that achieved with therapy in the control arm.

Primary Cutaneous Anaplastic Large Cell LymphomaMycosis FungoidesCutaneous T-Cell Lymphoma

Millennium Pharmaceuticals, Inc.131 participantsStarted Jun 2012

Los Angeles, California, United States • Palo Alto, California, United States • Chicago, Illinois, United States +38 more locations

A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)

Find Trials by Condition in New York State

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

A Study of CLR325 in Chronic Stable Heart Failure Patients.

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

CP-690-550 Ointment For Chronic Plaque Psoriasis

Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients

ACZ885 for the Treatment of Abdominal Aortic Aneurysm

Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

Korean Medicine for Symptomatic Lumbar Spinal Spondylolisthesis